What Drives the Value of a Shigella Vaccine?

The development and licensure of a safe and highly efficacious Shigella vaccine has been a priority in international public health circles for decades and would represent a great scientific achievement. Nonetheless, in the context of increasingly crowded and costly childhood immunization programs, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hausdorff, William P., Scheele, Suzanne, Giersing, Birgitte K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874986/
https://www.ncbi.nlm.nih.gov/pubmed/35214740
http://dx.doi.org/10.3390/vaccines10020282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874986/
https://www.ncbi.nlm.nih.gov/pubmed/35214740
http://dx.doi.org/10.3390/vaccines10020282

Ejemplares similares